JP2004537275A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004537275A5 JP2004537275A5 JP2002566376A JP2002566376A JP2004537275A5 JP 2004537275 A5 JP2004537275 A5 JP 2004537275A5 JP 2002566376 A JP2002566376 A JP 2002566376A JP 2002566376 A JP2002566376 A JP 2002566376A JP 2004537275 A5 JP2004537275 A5 JP 2004537275A5
- Authority
- JP
- Japan
- Prior art keywords
- dao
- polypeptide
- schizophrenia
- bipolar disorder
- depression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26188301P | 2001-01-16 | 2001-01-16 | |
| US30544501P | 2001-07-13 | 2001-07-13 | |
| US34521101P | 2001-10-22 | 2001-10-22 | |
| US33388101P | 2001-11-19 | 2001-11-19 | |
| PCT/IB2002/001262 WO2002066672A2 (en) | 2001-01-16 | 2002-01-15 | Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004537275A JP2004537275A (ja) | 2004-12-16 |
| JP2004537275A5 true JP2004537275A5 (https=) | 2006-01-05 |
Family
ID=27500728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002566376A Pending JP2004537275A (ja) | 2001-01-16 | 2002-01-15 | Ｄ−アミノ酸オキシダーゼおよびｄ−アスパラギン酸オキシダーゼのアンタゴニストを使用するｃｎｓ障害の処置 |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1412515A2 (https=) |
| JP (1) | JP2004537275A (https=) |
| KR (1) | KR20030066813A (https=) |
| CN (1) | CN1568370A (https=) |
| AU (1) | AU2002247939B2 (https=) |
| BR (1) | BR0206495A (https=) |
| CA (1) | CA2433866A1 (https=) |
| EA (1) | EA006654B1 (https=) |
| IL (1) | IL156865A0 (https=) |
| MX (1) | MXPA03006321A (https=) |
| WO (1) | WO2002066672A2 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60228954D1 (en) | 2001-05-03 | 2008-10-30 | Galileo Lab Inc | Pyruvatderivate |
| WO2003070743A1 (en) * | 2002-02-20 | 2003-08-28 | Ribozyme Pharmaceuticals, Inc. | RNA INTERFERENCE MEDIATED INHIBITION OF G72 AND D-AMINO ACID OXIDASE (DAAO) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| EP1291015A1 (en) | 2001-09-10 | 2003-03-12 | Lunamed AG | Dosage forms having prolonged active ingredient release |
| WO2003039540A2 (en) * | 2001-11-09 | 2003-05-15 | Sepracor Inc. | D-amino acid oxidase inhibitors for learning and memory |
| AU2002339696A1 (en) * | 2001-12-03 | 2003-06-17 | Genset S.A. | Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase inhibitors |
| US20060234221A1 (en) * | 2001-12-12 | 2006-10-19 | Genset S.A. | Biallelic markers of d-amino acid oxidase and uses thereof |
| GB0223424D0 (en) * | 2002-10-09 | 2002-11-13 | Imp College Innovations Ltd | Disease-associated gene |
| JP2007517056A (ja) | 2003-12-29 | 2007-06-28 | セプラコア インコーポレーテッド | ピロール及びピラゾールｄａａｏ阻害剤 |
| JP5367377B2 (ja) * | 2006-01-09 | 2013-12-11 | オクラホマ メディカル リサーチ ファウンデーション | 炎症性疾患治療のためのランチオニン関連化合物 |
| US7884124B2 (en) | 2006-06-30 | 2011-02-08 | Sepracor Inc. | Fluoro-substituted inhibitors of D-amino acid oxidase |
| US7902252B2 (en) * | 2007-01-18 | 2011-03-08 | Sepracor, Inc. | Inhibitors of D-amino acid oxidase |
| GB2456390A (en) * | 2008-01-15 | 2009-07-22 | Glaxo Group Ltd | Bipolar disorder treatments |
| CN102292094B (zh) | 2009-01-20 | 2013-08-14 | 洛杉矶生物医学研究所在哈伯-加州大学洛杉矶分校医疗中心 | 增强神经药方疗效的山梨酸与苯甲酸及其衍生物 |
| JP4462382B1 (ja) * | 2009-04-23 | 2010-05-12 | 学校法人北里研究所 | Ｄ−アスパラギン酸オキシダーゼおよびｄ−アミノ酸オキシダーゼに対する新規阻害剤 |
| WO2012135119A1 (en) * | 2011-03-25 | 2012-10-04 | Genomind, Llc | Biomarker-based detection and treatment of neurodegenerative depression |
| AU2013203395A1 (en) | 2012-03-30 | 2013-10-17 | Isis Pharmaceuticals, Inc. | Compositions and methods for modulating TAU expression for reducing seizure and modifying a neurodegenerative syndrome |
| TWI772856B (zh) | 2013-07-19 | 2022-08-01 | 美商百健Ｍａ公司 | 用於調節τ蛋白表現之組合物 |
| ES2936094T3 (es) | 2016-06-13 | 2023-03-14 | Syneurx Int Taiwan Corp | Cocristales de benzoato de sodio y usos de los mismos |
| RU2765625C2 (ru) | 2016-06-13 | 2022-02-01 | Сайньюрекс Интернэшнл (Тайвань) Корп. | Сокристаллы бензоата лития и их применения |
| US10336679B2 (en) | 2016-10-24 | 2019-07-02 | Syneurx International (Taiwan) Corp. | Polymorphic forms of sodium benzoate and uses thereof |
| US11369579B2 (en) | 2016-10-24 | 2022-06-28 | Syneurx International (Taiwan) Corp. | Polymorphic forms of sodium benzoate and uses thereof |
| US10098861B1 (en) | 2017-10-24 | 2018-10-16 | Syneurx International (Taiwan) Corp. | Pharmaceutical composition comprising sodium benzoate compound and clozapine, and uses thereof |
| CN108504752B (zh) * | 2018-06-26 | 2021-05-11 | 华中农业大学 | 一种与母猪繁殖性状关联的分子标记及应用 |
| CN111909907B (zh) * | 2020-07-08 | 2022-05-24 | 浙江工业大学 | 天冬氨酸氧化酶突变体、工程菌及其在氧化-还原偶联制备精草铵膦中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5668117A (en) * | 1991-02-22 | 1997-09-16 | Shapiro; Howard K. | Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments |
| EP1165836A2 (en) * | 1999-03-30 | 2002-01-02 | Genset | Schizophrenia associated genes, proteins and biallelic markers |
| WO2001009118A2 (en) * | 1999-07-29 | 2001-02-08 | Patrick T Prendergast | Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement |
| WO2001068104A1 (en) * | 2000-03-16 | 2001-09-20 | The Mclean Hospital Corporation | Compounds for the treatment of psychiatric or substance abuse disorders |
-
2002
- 2002-01-15 EP EP02717019A patent/EP1412515A2/en not_active Withdrawn
- 2002-01-15 MX MXPA03006321A patent/MXPA03006321A/es unknown
- 2002-01-15 BR BR0206495-2A patent/BR0206495A/pt not_active IP Right Cessation
- 2002-01-15 AU AU2002247939A patent/AU2002247939B2/en not_active Ceased
- 2002-01-15 IL IL15686502A patent/IL156865A0/xx unknown
- 2002-01-15 JP JP2002566376A patent/JP2004537275A/ja active Pending
- 2002-01-15 KR KR10-2003-7009412A patent/KR20030066813A/ko not_active Ceased
- 2002-01-15 CA CA002433866A patent/CA2433866A1/en not_active Abandoned
- 2002-01-15 CN CNA028066650A patent/CN1568370A/zh active Pending
- 2002-01-15 EA EA200300807A patent/EA006654B1/ru not_active IP Right Cessation
- 2002-01-15 WO PCT/IB2002/001262 patent/WO2002066672A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004537275A5 (https=) | ||
| Smeland et al. | Genetic overlap between schizophrenia and volumes of hippocampus, putamen, and intracranial volume indicates shared molecular genetic mechanisms | |
| Sawcer et al. | A whole genome screen for linkage disequilibrium in multiple sclerosis confirms disease associations with regions previously linked to susceptibility | |
| Volpi et al. | Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia | |
| Stark et al. | Genetic association study identifies HSPB7 as a risk gene for idiopathic dilated cardiomyopathy | |
| Cohen et al. | Polymorphisms of the dopamine D4 receptor and response to antipsychotic drugs | |
| Bottomly et al. | Evaluating gene expression in C57BL/6J and DBA/2J mouse striatum using RNA-Seq and microarrays | |
| Ciuculete et al. | meQTL and ncRNA functional analyses of 102 GWAS-SNPs associated with depression implicate HACE1 and SHANK2 genes | |
| CA2321226A1 (en) | Genomic sequence of the 5-lipoxygenase-activating protein (flap), polymorphic markers thereof and methods for detection of asthma | |
| JP2012503985A5 (https=) | ||
| Lutz et al. | New genetic approaches to AD: lessons from APOE-TOMM40 phylogenetics | |
| Dey et al. | SNP-to-gene linking strategies reveal contributions of enhancer-related and candidate master-regulator genes to autoimmune disease | |
| Betcheva et al. | Whole-genome-wide association study in the Bulgarian population reveals HHAT as schizophrenia susceptibility gene | |
| JP2012507291A5 (https=) | ||
| US20080206768A1 (en) | Predicting a response to olanzapine | |
| US20050233321A1 (en) | Identification of novel polymorphic sites in the human mglur8 gene and uses thereof | |
| WO2008076449A2 (en) | Predicting a response to olanzapine | |
| CN103571846B (zh) | Atp6v1b2基因突变体及其应用 | |
| US20090215043A1 (en) | Polymorphic GHSR Nucleic Acids And Uses Thereof | |
| KR102066663B1 (ko) | 유전성 말초 신경질환 진단용 마커 및 그의 용도 | |
| CN105886609A (zh) | 药物不良反应风险评估方法及其装置 | |
| CA2469561A1 (en) | Methods for determining transcriptional activity | |
| Tore et al. | Application of a new method for GWAS in a related case/control sample with known pedigree structure: identification of new loci for nephrolithiasis | |
| JP5376802B2 (ja) | タンパク質多型と冠動脈心疾患との関係 | |
| US20150315640A1 (en) | Identification of the dcps gene on 11q24.2, which encodes the human decapping enzyme scavenger, in non-syndromic autosomal recessive mental retardation, diagnostic probes thereof and methods of identifying subjects with same |